Wire Stories

Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting the SARS-CoV-2 Delta Variant and Other Variants of Concern

The Phase 1/2/3 trial to be funded and sponsored by Arcturus’ manufacturing partner Vinbiocare ARCT-154 to be developed in parallel…

5 years ago

LianBio Appoints Pascal Qian as General Manager of China

SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--LianBio, a biotechnology company dedicated to bringing paradigm-shifting medicines to patients in China and other major…

5 years ago

SaNOtize inks agreement with Indian biotech Glenmark to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

Nitric oxide (NO) has antimicrobial properties with direct proven effect on SARS-CoV-2 Nitric Oxide Nasal Spray (NONS) has been tested…

5 years ago

Coca-Cola Europacific Partners Indonesia Taps 8×8 CPaaS to Enhance Mobile Experience for Business-to-Business (B2B) Customers in Indonesia

Deploys 8x8 SMS API to Ensure Mobile App Security with One-Time Password (OTP) Multi-Factor Authentication CAMPBELL, Calif.--(BUSINESS WIRE)--8x8, Inc. (NYSE:…

5 years ago

CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Accepted by China’s National Medical Products Administration

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a leading China-based global rare disease-focused biopharmaceutical company committed to the research, development…

5 years ago

Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021

BANGKOK--(BUSINESS WIRE)--#EarningsDate--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to…

5 years ago

Esri Signs Goodwill Protocol with Atlas University

Turkish Institution Will Offer GIS Training, Provide Space for Research and Development REDLANDS, Calif.--(BUSINESS WIRE)--Esri, the global leader in location…

5 years ago

IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual-Targeted CAR-T Drug Receives Two IND Clearances, Enters Clinical Trials

NMPA’s Clearance of CT120 Marks Major Milestone in Treatment for B-Cell Malignancies PLEASANTON, Calif. & NANJING, China & SHANGHAI--(BUSINESS WIRE)--#Biopharmaceutical--IASO…

5 years ago

News Corp to Acquire OPIS

Leading Data and Analytics Provider for Energy and Commodities Markets Will Provide New Pillars of Growth for Dow Jones Growing,…

5 years ago

Overland Pharmaceuticals Appoints Roger Luo, Ph.D. as Chief Development Officer

Experienced pharmaceutical research and development strategist brings deep expertise in advancing innovative cancer medicines SHANGHAI & BOSTON--(BUSINESS WIRE)--Overland Pharmaceuticals (“Overland”),…

5 years ago